Mapez is indicated in the following diseases
Emotional disturbances: Anxiety and tension states, as adjuvant therapy for anxiety in depression patients, nervous tension, restlessness and anxiety and tension related insomnia. As an adjuvant to treatment of underlying disease responsible for functional or psychosomatic impairments of various organs caused by anxiety and tension.
Cardiovascular and respiratory systems: Pseudoangina pectoris, precordial; anxiety, tachycardia, emotiogenic hypertension, dyspnea and hyperventilation.
Gastrointestinal tract: Irritable bowel syndrome, ulcerative colitis, epigastric pain, spasm, meteorism and diarrhoea.
Urogenital tract: Irritable bladder, urinary frequency and dysmenorrhea.
Other psychosomatic disturbances: Psychogenic headache, psychogenic dermatoses.
Mapez is suitable for treatment of anxiety and tension states due to chronic organic disease and as an adjuvant to psychotherapy in psychoneurosis.